# Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis

> **NCT04685031** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Komar University of Science and Technology** · enrollment: 110 (estimated)

## Conditions studied

- Phlebitis

## Interventions

- **DRUG:** Nitroglycerin ointment
- **DRUG:** Clobetasol Topical

## Key facts

- **NCT ID:** NCT04685031
- **Lead sponsor:** Komar University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2020-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04685031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04685031, "Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04685031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*